PETS Stock Overview
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States.
PetMed Express Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$24.01|
|52 Week High||US$57.00|
|52 Week Low||US$23.40|
|1 Month Change||-8.39%|
|3 Month Change||-11.24%|
|1 Year Change||-22.22%|
|3 Year Change||6.00%|
|5 Year Change||14.33%|
|Change since IPO||1,820.80%|
Recent News & Updates
PetMed Express: Avoid For Now
PetMed Express is aiming to recover its growth trajectory. Cost of customer acquisition is rapidly increasing with competition. Avoid the stock until a visible turnaround or sizable valuation haircut.
PetMed Express Needs A White Knight
Save for a brief July dip, PETS stock is at its lowest level in 18 months. Fundamental valuation suggests the stock is oversold; competitive dynamics argue otherwise. A new CEO could perhaps right the ship, but the easiest path to success seems to be a sale to a larger industry player that can accelerate growth. Betting on that sale, right now, seems unwise. PETS increasingly looks like a value trap.
|PETS||US Online Retail||US Market|
Return vs Industry: PETS exceeded the US Online Retail industry which returned -25.9% over the past year.
Return vs Market: PETS underperformed the US Market which returned 6.6% over the past year.
|PETS Average Weekly Movement||5.7%|
|Online Retail Industry Average Movement||10.5%|
|Market Average Movement||6.6%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: PETS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: PETS's weekly volatility has decreased from 13% to 6% over the past year.
About the Company
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PetMed Express Fundamentals Summary
|PETS fundamental statistics|
Is PETS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PETS income statement (TTM)|
|Cost of Revenue||US$203.17m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Jan 24, 2022
|Earnings per share (EPS)||1.25|
|Net Profit Margin||8.86%|
How did PETS perform over the long term?See historical performance and comparison
5.0%Current Dividend Yield
Is PetMed Express undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PETS ($24.01) is trading below our estimate of fair value ($34.16)
Significantly Below Fair Value: PETS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: PETS's PE Ratio (19.3x) is in line with the US Online Retail industry average.
PE vs Market: PETS is poor value based on its PE Ratio (19.3x) compared to the US market (16.7x).
Price to Earnings Growth Ratio
PEG Ratio: PETS is poor value based on its PEG Ratio (1.1x)
Price to Book Ratio
PB vs Industry: PETS is overvalued based on its PB Ratio (3.4x) compared to the US Online Retail industry average (2.7x).
How is PetMed Express forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PETS's forecast earnings growth (17% per year) is above the savings rate (2%).
Earnings vs Market: PETS's earnings (17% per year) are forecast to grow faster than the US market (13.1% per year).
High Growth Earnings: PETS's earnings are forecast to grow, but not significantly.
Revenue vs Market: PETS's revenue (4.4% per year) is forecast to grow slower than the US market (9.2% per year).
High Growth Revenue: PETS's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PETS's Return on Equity is forecast to be low in 3 years time (18.9%).
How has PetMed Express performed over the past 5 years?
Historical annual revenue growth
Earnings and Revenue History
Quality Earnings: PETS has high quality earnings.
Growing Profit Margin: PETS's current net profit margins (8.9%) are lower than last year (9.8%).
Past Earnings Growth Analysis
Earnings Trend: PETS's earnings have grown by 0% per year over the past 5 years.
Accelerating Growth: PETS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PETS had negative earnings growth (-16.1%) over the past year, making it difficult to compare to the Online Retail industry average (78.8%).
Return on Equity
High ROE: PETS's Return on Equity (17.8%) is considered low.
How is PetMed Express's financial position?
Financial Position Analysis
Short Term Liabilities: PETS's short term assets ($133.4M) exceed its short term liabilities ($16.3M).
Long Term Liabilities: PETS's short term assets ($133.4M) exceed its long term liabilities ($1.6M).
Debt to Equity History and Analysis
Debt Level: PETS is debt free.
Reducing Debt: PETS has not had any debt for past 5 years.
Debt Coverage: PETS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PETS has no debt, therefore coverage of interest payments is not a concern.
What is PetMed Express's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PETS's dividend (5%) is higher than the bottom 25% of dividend payers in the US market (1.36%).
High Dividend: PETS's dividend (5%) is in the top 25% of dividend payers in the US market (3.55%)
Stability and Growth of Payments
Stable Dividend: PETS's dividends per share have been stable in the past 10 years.
Growing Dividend: PETS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (92.6%), PETS's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: PETS's dividends in 3 years are not forecast to be well covered by earnings (107.5% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Matt Hulett (50 yo)
Mr. Matthew N. Hulett, also known as Matt, serves as Chief Executive Officer, President & Director at PetMed Express, Inc. since August 30, 2021. He served as Co-President of Rosetta Stone, Inc. since Janu...
Experienced Management: PETS's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Experienced Board: PETS's board of directors are considered experienced (3.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PetMed Express, Inc.'s employee growth, exchange listings and data sources
- Name: PetMed Express, Inc.
- Ticker: PETS
- Exchange: NasdaqGS
- Founded: 1996
- Industry: Internet and Direct Marketing Retail
- Sector: Retail
- Implied Market Cap: US$485.200m
- Shares outstanding: 20.21m
- Website: https://www.1800petmeds.com
Number of Employees
- PetMed Express, Inc.
- 420 South Congress Avenue
- Delray Beach
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/21 23:43|
|End of Day Share Price||2022/01/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.